Organophosphate Poisoning
📧 Sign up to get email alerts when something new happens for Organophosphate Poisoning.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-10-03Clinical Trial Update: Role of Intralipid in Management of Organophosphorus Poisoning [Phase 2, Phase 3]
The Phase 2/Phase 3 clinical trial NCT04393103 evaluating intravenous lipid emulsion (Intralipid) for organophosphate poisoning has been wit…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Effectiveness of Calcium Channel Blockade for OP and Carbamate Pesticide Poisoning [Phase 3]
Phase 3 trial evaluating whether calcium channel blockade improves outcomes in organophosphate and carbamate pesticide poisoning; the study …
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: A Study to Evaluate the Intramuscular Administration of Scopolamine [Phase 1]
Phase 1 study evaluating intramuscular scopolamine as a medical countermeasure for organophosphate poisoning was terminated; results have be…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Outcome of Moderate Severity in OPC Poisoning Patients When Treated With Pralidoxime [Phase 2]
A Phase 2 trial evaluating pralidoxime for moderate organophosphate poisoning reports the outcomes of treatment in this condition.
-
FDA approval · 2024-01-08FDA Approved: ATROPINE SULFATE — Original Application (Lifestar Pharma LLC)
FDA approved the original application for atropine sulfate (generic) from Lifestar Pharma LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-05-26FDA Approved: ATNAA ATROPINE AND PRALIDOXIME CHLORIDE AUTO-INJECTOR — Supplemental Application (Meridian Medical Technologies, LLC)
FDA approved a supplemental application for ATNAA Atropine and Pralidoxime Chloride Auto-Injector from Meridian Medical Technologies. This a…
-
FDA approval · 2022-05-17FDA Approved: DUODOTE — Supplemental Application (Meridian Medical Technologies LLC)
FDA approved a supplemental application for DUODOTE (atropine and pralidoxime chloride) from Meridian Medical Technologies LLC.
-
FDA approval · 2022-01-26FDA Approved: ATROPINE SULFATE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's atropine sulfate under an Original Application (ANDA), granting clearance for a generic atropine s…
-
FDA approval · 2021-07-26FDA Approved: ATROPINE SULFATE — Original Application (Accord Healthcare, Inc.,)
FDA approved Accord Healthcare's atropine sulfate as an original generic product (ANDA 212868). The approval supports the generic atropine s…
-
FDA approval · 2021-03-19FDA Approved: ATROPINE SULFATE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's atropine sulfate product under an Original Application (ANDA213424), making a generic version available. At…
-
FDA approval · 2020-11-20FDA Approved: ATROPEN AUTO-INJECTOR — Supplemental Application (Meridian Medical Technologies LLC)
The FDA approved a supplemental application for the Atropen auto-injector (atropine) from Meridian Medical Technologies LLC.
-
FDA approval · 2020-10-05FDA Approved: ATROPINE SULFATE — Original Application (International Medication Systems, Limited)
The FDA approved the original application for atropine sulfate from International Medication Systems, Limited (ANDA 212461), providing a gen…
-
FDA approval · 2020-05-22FDA Approved: ATNAA ATROPINE AND PRALIDOXIME CHLORIDE AUTO-INJECTOR — Supplemental Application (Meridian Medical Technologies, LLC)
FDA approved a supplemental application for the ATNAA atropine and pralidoxime chloride auto-injector from Meridian Medical Technologies. Th…
-
FDA approval · 2018-07-09FDA Approved: N/A — Original Application (Rafa Laboratories, Ltd.)
FDA approved Rafa Laboratories, Ltd.'s original application for Atropine Injection, 2 mg.
-
CLINICAL_TRIALS trial_result · 2018-06-21Clinical Trial Update: To Study the Effects of Lipid Emulsion on Hemodynamics in Organophosphate Compound Poisoning [Phase 4]
A Phase 4 clinical trial studying the effects of intravenous lipid emulsion on hemodynamics in organophosphate poisoning has completed.
-
FDA approval · 2017-10-06FDA Approved: DUODOTE — Supplemental Application (Meridian Medical Technologies LLC)
The FDA approved a supplemental application for DUODOTE (atropine and pralidoxime chloride) from Meridian Medical Technologies LLC.
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: A Pilot Study Using Rocuronium to Prevent Intermediate Syndrome After Organophosphorus Insecticide Poisoning [Phase 2, Phase 3]
A Phase 2/3 pilot trial evaluated whether rocuronium can prevent intermediate syndrome after organophosphate poisoning. The study has comple…
-
FDA approval · 2016-11-03FDA Approved: DUODOTE — Supplemental Application (Meridian Medical Technologies LLC)
The FDA approved a supplemental application for DUODOTE (atropine and pralidoxime chloride) from Meridian Medical Technologies LLC, updating…
-
FDA approval · 2016-11-03FDA Approved: ATNAA ATROPINE AND PRALIDOXIME CHLORIDE AUTO-INJECTOR — Supplemental Application (Meridian Medical Technologies, LLC)
FDA approves a supplemental application for the ATNAA atropine and pralidoxime chloride auto-injector from Meridian Medical Technologies, re…
-
FDA approval · 2016-06-08FDA Approved: DUODOTE — Supplemental Application (Meridian Medical Technologies LLC)
FDA approved a supplemental application for DUODOTE (atropine and pralidoxime chloride) from Meridian Medical Technologies LLC. The action r…
-
FDA approval · 2016-05-27FDA Approved: ATNAA ATROPINE AND PRALIDOXIME CHLORIDE AUTO-INJECTOR — Supplemental Application (Meridian Medical Technologies, LLC)
FDA approved a supplemental application for the ATNAA Atropine and Pralidoxime Chloride Auto-Injector from Meridian Medical Technologies, LL…
-
FDA approval · 2016-05-27FDA Approved: ATROPEN AUTO-INJECTOR — Supplemental Application (Meridian Medical Technologies LLC)
FDA documents a supplemental application for the AtroPen Auto-Injector (atropine) from Meridian Medical Technologies LLC.
-
FDA approval · 2016-04-25FDA Approved: DUODOTE — Supplemental Application (Meridian Medical Technologies LLC)
The FDA approved a supplemental application for DUODOTE, a combination of atropine and pralidoxime chloride from Meridian Medical Technologi…
-
FDA approval · 2016-04-25FDA Approved: ATNAA ATROPINE AND PRALIDOXIME CHLORIDE AUTO-INJECTOR — Supplemental Application (Meridian Medical Technologies, LLC)
The FDA approved a supplemental application for the ATNAA atropine and pralidoxime chloride auto-injector from Meridian Medical Technologies…
-
FDA approval · 2016-03-02FDA Approved: DUODOTE — Supplemental Application (Meridian Medical Technologies LLC)
The FDA approved a supplemental application for DUODOTE, a combination product of atropine and pralidoxime chloride, submitted by Meridian M…